Explore published research on pregnancy, including study methods and limitations.
A major 1986 pharmacological review found cannabis's greatest health concern was its impact on youth development, while finding no proven brain damage and limited physical dependence in adults.
In 131 children followed from birth, prenatal cigarette exposure was linked to lower reading and language scores in a dose-dependent pattern, while prenatal marijuana exposure showed no significant effect.
All four common recreational substances (alcohol, caffeine, nicotine, marijuana) enter breast milk and can affect both milk production and the nursing infant.
Prenatal cigarette exposure reduced birth weight but children caught up quickly. Prenatal marijuana showed no effects at birth but was linked to smaller head circumference by early adolescence.
Study discovering endocannabinoids in human reproductive fluids and cannabinoid receptors on sperm, finding that cannabinoid compounds and THC impaired sperm capacitation and fertilizing potential.
fMRI study showing young adults prenatally exposed to marijuana had increased brain activation during impulse control tasks and more errors, with effects persisting after controlling for current drug use.
Review found cannabis-based MS medicines had mild side effects in trials but urged caution for psychosis-prone and pregnant patients, noting therapeutic benefits remained modest.
fMRI study of 18-22 year olds from a 20-year longitudinal study found altered brain activation during memory tasks in those prenatally exposed to marijuana, despite normal task performance.
Early-life cannabis exposure was linked to subtle cognitive and psychiatric outcomes, with animal studies offering mechanistic clues but not human behavior.
Survey of 84 medical cannabis users found 65% used cannabis during pregnancy, with 92% of those who used it for morning sickness rating it effective. Fetal safety was not assessed.
Lab study found THC reduced sperm motility by up to 56% and inhibited the acrosome reaction by up to 57% at concentrations matching recreational cannabis use levels.
Rats exposed to a synthetic cannabinoid in the womb showed permanent, region-specific changes in their brain's endocannabinoid system as adults.
Mouse study mapped how the uterus creates precise endocannabinoid gradients essential for embryo implantation, with disruption leading to compromised pregnancy outcomes.
Among 351 Hispanic women, pre-pregnancy marijuana use was associated with 23-49% lower likelihood of quitting smoking at pregnancy onset, alongside stress and heavy smoking.
Chronic cannabis extract reduced sperm count, motility, and testosterone in male mice, with direct effects on testicular cannabinoid receptors.
Review of endocannabinoid roles in reproduction: THC disrupted menstrual cycles and egg development in females, sperm production and motility in males.
Prenatal cannabis decreased D2 receptor expression in human fetal brain reward center; in rats, THC during pregnancy caused lasting epigenetic changes increasing offspring addiction vulnerability.
Review of how prenatal cannabis and cigarettes cause lasting brain changes: cannabis altered dopamine D2 receptors through epigenetic mechanisms, potentially programming lifelong addiction vulnerability.
First reported case of cannabinoid hyperemesis syndrome in pregnancy, highlighting the need to screen for cannabis use in treatment-resistant vomiting.
The endocannabinoid system is active in embryos before brain development begins, suggesting early pregnancy cannabis exposure could disrupt fundamental developmental processes.
Review found cannabis crosses the placenta and enters breast milk, with evidence suggesting adverse effects on fetal brain development that may persist into adulthood.
Hawaii population survey found women with severe pregnancy nausea were 63% more likely to report marijuana use during pregnancy, though the direction of this relationship is unclear.
Large case-control study found cannabis-positive cord tests were associated with 2.3x higher odds of stillbirth, with smoking showing an independent dose-response relationship.
ACOG formally recommended that pregnant women stop marijuana use due to neurodevelopmental concerns, and that obstetricians not prescribe marijuana during pregnancy or lactation.
A pregnant woman with multiple admissions for severe vomiting and esophageal tears was eventually diagnosed with CHS after compulsive bathing behavior was noted.
Case report of CHS in pregnancy mistaken for hyperemesis gravidarum, reinforcing the need for marijuana history in pregnant patients with severe, unexplained vomiting.
Review found cannabis disrupts male fertility through the endocannabinoid system, affecting testosterone, sperm production, motility, and fertilization capacity.
Review found marijuana crosses the placenta and appears in breast milk, with evidence linking prenatal exposure to growth restriction and neurological development effects, though data quality is limited.
Study of 49 women found endocannabinoid enzymes in the uterine lining change across the menstrual cycle, with degrading enzymes peaking during the implantation window.
A review of animal research found that prenatal cannabinoid exposure can produce lasting immune dysfunction in offspring through epigenetic mechanisms like altered DNA methylation and microRNA.
A review found minimal evidence for prenatal cannabis exposure causing childhood aggression, and only a marginal, largely confounded association between adolescent use and aggressive behavior.
In a study of 344 Aboriginal women, 20.5% used cannabis during pregnancy, and their babies were 565g lighter with 3.9x higher odds of low birth weight after adjusting for social factors.
The endocannabinoid system regulates normal placenta development; THC can disrupt trophoblast proliferation, death, and function, providing a mechanism for cannabis-related fetal growth restriction.
Among 273 pregnant former smokers, 14% had a lifetime cannabis use disorder, with having multiple psychiatric disorders as the overwhelming strongest predictor (36x odds).
Comparative genomics reveals important differences between baboon and human endocannabinoid system genes, particularly in CB2 receptors and metabolic enzymes, with implications for translating primate drug studies to humans.
Young adults prenatally exposed to marijuana showed altered brain activation (increased left posterior activity) during executive function tasks despite normal performance, suggesting neural compensation 18-22 years after exposure.
Review finds cannabis can alter epigenetic marks controlling gene expression in brain and body, with emerging evidence suggesting some changes may pass to offspring.
Among 913 premenopausal women, heavy tobacco smoking reduced ovarian reserve markers by 56%, but marijuana use showed no association with antimullerian hormone levels.
Rat pups born to mothers on high-fat diets developed early obesity with sex-specific alterations in cannabinoid receptor expression across different fat tissue types.
ACOG's 2017 committee opinion formally recommended against cannabis use during pregnancy and lactation based on neurodevelopment concerns and insufficient safety data.
Review finding growing evidence that prenatal marijuana exposure is associated with lower birth weight, preterm birth, and impaired neurodevelopment, with THC also found in breast milk.
Study of 804 neonates found no strong evidence that maternal cannabis use during pregnancy alters DRD4 dopamine receptor gene methylation in infants.
Australian survey found 95% of clinicians asked pregnant women about cigarettes but only 58% about cannabis and 13% about e-cigarettes, revealing gaps in prenatal exposure screening.
Study of 645 meconium samples finding good agreement between maternal self-reports and objective testing for tobacco but poor agreement for cannabis and alcohol, suggesting underreporting of prenatal exposure.
Survey of 417 family physicians finding 92% viewed marijuana as unsafe in pregnancy but only 63% consistently screened for it, with only 18% screening for all substances.
Review of cannabis legalization's unintended pediatric consequences, covering prenatal exposure, accidental childhood ingestion, adolescent use, and the need for rigorous CBD epilepsy trials.
Both maternal (38% increase) and paternal (44% increase) cannabis use during pregnancy predicted offspring psychotic-like experiences at age 10, suggesting shared genetics rather than direct prenatal exposure.
In legalized Colorado, 5.7% of pregnant women used cannabis, with a 50% increased risk of low birth weight independent of tobacco, though preterm birth and NICU rates were not elevated.
Analysis of 550 tweets found most discussion of marijuana and pregnancy was neutral in tone, while linked sources focused on negative outcomes like impaired brain development and low birth weight.
Mystery caller study found 69% of 400 Colorado dispensaries recommended cannabis for first-trimester nausea, mostly based on personal opinion, with only 32% voluntarily suggesting medical consultation.
Longitudinal study of 247 families found prenatal tobacco effects were stronger in girls, and a bidirectional cycle where toddler behavior problems predicted increased maternal cannabis use.
Major review documented US increases in cannabis potency, use disorders, ER visits, and fatal crashes alongside growing perception of harmlessness, while medical marijuana laws showed no effect on adolescent use.
Case of a pregnant woman repeatedly hospitalized for vomiting that was actually CHS, not pregnancy-related. Diagnosis was delayed because symptoms mimicked hyperemesis gravidarum.
Mouse study found 30 days of daily THC did not affect sperm function, testicular structure, IVF outcomes, or DNA methylation, contradicting prior assumptions about THC harming male fertility.
First case report of the triad of CHS, H. pylori gastritis, and preeclampsia in a cannabis-using pregnant woman, raising questions about cannabinoid-related pathways in pregnancy complications.
Obstetrics review found marijuana crosses the placenta and enters breast milk, with meta-analyses and cohort studies suggesting associations with growth restriction, preterm birth, and neurobehavioral effects. Women advised to avoid use during pregnancy and lactation.
Cannabis use altered DNA methylation at nearly 4,000 sites in human sperm, affecting Hippo Signaling and cancer pathways. Same pathways were affected in THC-exposed rat sperm, and changes overlapped with offspring brain methylation.
Review reveals that cannabis exposure during development can create lasting epigenetic changes - modifications to gene expression that persist across the lifespan and have been observed transmitting to the next generation.
Prenatal cannabinoid exposure in rats accelerated early motor development but worsened alcohol-related motor impairment specifically in females, with combined exposure showing complex interactions.
A review for pediatric gynecologists found adolescent marijuana use carries risks for brain development, reproductive health, and mental health, with limited research on gynecological-specific effects.
Review showing cannabinoids cross the placenta and may impair fetal immune development through cytokine disruption, lymphoid cell death, and epigenetic changes with potentially lifelong consequences.
Analysis of the landmark ABCD study found prenatal cannabis exposure associated with increased psychosis proneness in children, especially when mothers continued use after knowing they were pregnant.
Review for fetal/neonatal specialists covers how the endocannabinoid system guides brain development and why exogenous cannabinoids during pregnancy, infancy, or adolescence can disrupt normal neural development.
Mouse study shows paternal cannabinoid (CB2) exposure alters sperm DNA methylation and reduces offspring growth through epigenetic changes transmitted in sperm to the placenta.
Theoretical adverse outcome pathway proposes that cannabis contaminated with organophosphate pesticides may compound developmental neurotoxicity through overlapping molecular targets.
Paternal THC exposure in rats (modest dose, 12 days) caused long-lasting attention impairments in offspring, likely through epigenetic changes in sperm.
Prenatal cannabis exposure alters dopamine, serotonin, GABA, and other neurotransmitter systems in offspring, with effects that vary by brain region and sex.
Cannabis use alters DNA methylation in human sperm, potentially affecting offspring development and possibly future generations through epigenetic inheritance.
Review finds prenatal marijuana exposure is linked to growth restriction and neurodevelopmental effects, but most evidence comes from an era of lower-potency cannabis.
Four-year follow-up found children prenatally exposed to cocaine/cannabis had more ER visits, hospitalizations, and family disruption than unexposed children.
Analysis of 6,061 women found stressful life events like partner incarceration and job loss predicted cannabis use before, during, and after pregnancy.
Lab study found synthetic cannabinoids and THC all triggered programmed cell death in human placental cells, with synthetics being more potent than THC.
Review concludes there is no known safe level of cannabis in pregnancy, with prenatal exposure linked to neurodevelopmental effects persisting into adulthood.
Survey of 478 pregnant Canadians found high awareness that cannabis reaches the fetus, but 4.2% continued using, with provider counseling paradoxically more common among users.
Adolescent rat offspring exposed to THC during fetal development showed impaired emotional memory, reduced neuropeptide Y neurons, and increased alcohol-seeking behavior, suggesting prenatal THC may create lasting vulnerability.
Female rat offspring exposed to a cannabinoid agonist prenatally had reduced ovarian reserve in adulthood, an effect mediated by CB1 receptors. The delay between exposure and impact suggests a programmed developmental effect.
Among 503,000+ Ontario births, prenatal cannabis exposure was associated with 51% higher autism diagnosis rate in offspring (HR 1.51), though residual confounding cannot be excluded.
Prenatal THC exposure selectively destroyed CCK-containing hippocampal interneurons in male but not female mice, causing lasting memory deficits and disrupted brain oscillations through a CB1 receptor-dependent mechanism.
Case report of a 29-year-old pregnant woman with cannabinoid hyperemesis syndrome caused by chronic cannabis use, highlighting the need to consider CHS in the differential diagnosis of pregnancy-related vomiting.
Review finds prenatal cannabis exposure is not linked to a unique birth defect pattern but is associated with impaired attention and memory, plus increased depression, anxiety, and delinquency in offspring.
Rat study found offspring of THC-exposed fathers showed hyperactivity and cognitive deficits despite mothers never being exposed, suggesting paternal cannabis use before conception can affect offspring.
Review found early evidence that medical cannabis may help behavioral symptoms in children with autism or fetal alcohol spectrum disorder, and severe nausea in pregnancy, but data remain very limited.
First study to detect THC in human semen, found in 2 of 10 chronic cannabis users with moderate correlation to blood levels. Semen parameters were normal despite heavy use.
Review found prenatal cannabis exposure associated with lower birth weight, neonatal effects, and developmental delays in the first 2 years, with significant research gaps remaining.
Systematic review found only 2 eligible studies on cannabis exposure during breastfeeding, with conflicting results on infant development, exposing a critical evidence gap.
Systematic review found prenatal cannabis exposure may be linked to ADHD and affective symptoms in offspring, but the topic is under-researched despite common use.
THC altered DNA methylation at 7 neurodevelopmental genes in rat sperm, overlapping with nicotine effects and enriched for autism candidate genes.
Cannabis use linked to widespread methylation changes in autism gene DLGAP2 in human sperm, with similar changes found in rat offspring brains after paternal THC exposure.
Paternal THC exposure in rats caused dose-dependent, lifelong cholinergic brain deficits in offspring from adolescence through middle age.
Among nearly 12,000 children in the ABCD Study, prenatal cannabis exposure was associated with multiple sleep disturbances at ages 9-10, even after controlling for other prenatal exposures.
Analysis of online health Q&A found nearly half of provider responses about perinatal cannabis did not discourage use, and 8.8% described it as safe, revealing significant gaps in safety messaging.
Analysis of 2002-2014 survey data found medical marijuana laws increased cannabis use among women but did not reduce opioid misuse, with divergent effects for pregnant versus parenting women.
A review found gestational cannabis exposure is associated with impaired placental blood flow, smaller birth size, and potential neurodevelopmental and metabolic risks in children, though definitive evidence remains limited.
A Nature Reviews Neuroscience paper found cannabis exposure during pregnancy and adolescence impairs brain development through epigenetic changes that persist into adulthood and can be passed to future generations.
A study of 2,577 mother-child pairs found prenatal cannabis exposure (with tobacco) was linked to higher stress hormone levels in children at age 6, suggesting lasting effects on the developing stress response system.
Study of 318 IVF follicular fluid samples found cannabis exposure altered cannabinoid receptor and DNA methylation enzyme expression in granulosa cells, with cannabis detection tripling after Canadian legalization.
Retrospective study of 722 IVF patients found no significant differences in implantation, pregnancy, or embryo quality between cannabis users and non-users.
Prospective study of 409 infertility patients found current marijuana use doubled the odds of abnormal sperm shape and tripled the odds of low volume, but was unexpectedly associated with better motility.
A study of 604 pregnant women found continued cannabis use was associated with higher anxiety and depression scores, and women with more depression symptoms were nearly 3 times more likely to keep using rather than quit.
A study of 101 low-income pregnant women found sexual partner violence predicted marijuana use during pregnancy, while physical violence and childhood adversity predicted cigarette use at different intensity levels.
A study of 20 breastfeeding mothers found THC concentrated in breast milk at 7 times plasma levels, with mothers increasing cannabis use in the early postpartum period.
Children exposed to marijuana before birth showed more sleep problems, withdrawal symptoms, and aggressive behaviors at age 3.5 compared to non-exposed children, but executive function was not affected.
ABCD study of 11,489 children finds prenatal cannabis exposure associated with greater psychopathology, sleep problems, higher BMI, and lower cognition at ages 9-11.
Rat study finds prenatal cannabinoid exposure paradoxically enhances mitochondrial function and promotes neuronal survival in offspring cerebellum, unlike harmful effects seen in other brain regions.
Ecological analysis finds US states with higher cannabis use and legal cannabis have higher pediatric leukemia rates, though the study design cannot prove individual-level causation.
Rat study finds prenatal alcohol and THC have opposing effects on hippocampal inhibitory neurons, with sex-specific effects and complex interactions when both are present.
PNAS study links maternal cannabis use to suppressed placental immune genes, elevated cortisol, and increased anxiety and hyperactivity in children aged 3-6.
Rat study finds prenatal THC creates a latent dopamine dysfunction in offspring that emerges as psychotic-like behavior only when triggered by stress or drug challenge.
Study found that cannabis-related DNA methylation changes in sperm, concentrated at developmental genes, were significantly diminished after 77 days of abstinence, suggesting reversibility.
Systematic review of 15 studies found marijuana was associated with reduced sperm count, motility, and morphology, though evidence is observational and larger trials are needed.
Survey of 36,391 women found recreational cannabis legalization was associated with 2.37x higher preconception and 1.51x higher prenatal cannabis use compared to non-legal states.
Fetal brain imaging found prenatal cannabis exposure altered hippocampal connectivity to multiple brain regions, with patterns linked to less favorable outcomes at age 5.
First study of developmental CBD exposure found mice exposed in utero and during nursing showed increased anxiety and thousands of brain DNA methylation changes as adults, despite known benefits of direct CBD exposure.
Prospective cohort found marijuana-only use in pregnancy was linked to 66% higher risk of small birth size and 126% higher risk of very small birth size, independent of tobacco exposure.
A study of 8,008 pregnant women found cannabis use altered placental blood vessel development markers and was associated with higher risk of pregnancy complications.
Children exposed to prenatal cannabis had higher BMI and body fat at age 10, but similar associations with paternal use suggest family lifestyle factors rather than direct fetal effects.
In the ABCD Study, prenatal cannabis exposure was linked to more attention and behavior problems at ages 9-10, but no differences in cognitive performance or brain scans.
A survey of 46 new mothers found most knew marijuana may be harmful while breastfeeding, but fewer than half knew THC enters breast milk, and only 30% received postnatal counseling.
Longitudinal research links prenatal cannabis exposure to lasting effects on behavior, memory, and substance use from childhood through adulthood.
Pregnant women with any cannabis use history were 6 to 11 times more likely to smoke cigarettes during pregnancy and postpartum.
Large case-control study found no significant association between maternal cannabis use around pregnancy and autism spectrum disorder in children.
Review found cannabis may reduce opioid use for gynecological pain but noted unclear risks during pregnancy due to lack of controlled trials.
Review found THC disrupts reproductive hormones, egg development, and sperm function through the hypothalamic-pituitary-gonadal axis, though mostly from preclinical evidence.
First study of its kind found cannabis exposure altered DNA methylation at 3,679 sites in human ovarian follicle cells, some in a dose-dependent manner.
Birth cohort study found prenatal opioid exposure doubled ADHD risk, with cannabis and alcohol interactions increasing risk further.
Canadian clinical guideline recommends avoiding cannabis during pregnancy and breastfeeding, with harm reduction strategies when abstinence is not feasible.
Ethics analysis found discouraging breastfeeding in cannabis-using mothers may cause net harm, compromise autonomy, and worsen racial health disparities.
Six rhesus macaques given daily THC edibles experienced 58% testicular volume loss and hormone shifts consistent with testicular failure, in a dose-dependent pattern.
Mouse pups exposed to CBD prenatally showed sex-specific disruptions: males gained extra weight and changed vocalizations, while females had impaired motor and discrimination abilities.
Animal studies consistently show prenatal cannabis/THC exposure causes cognitive, emotional, and drug sensitivity changes in offspring, supporting their classification as developmental toxicants.
Among 1,540 newborns with meconium drug testing, THC-exposed infants weighed 0.16 kg less and had 1.9x the odds of low birth weight.
Among 256 pregnant patients, continued cannabis use through delivery was linked to 10% lower birthweight, and mothers with higher childhood trauma scores were more likely to keep using.
Analysis of an online pregnancy forum found cannabis-using mothers primarily seek information about drug testing, CPS involvement, and state-specific legal consequences rather than health effects.
Comprehensive review found cannabis exposure linked to adverse effects across reproductive health: altered fertility, preterm birth, impaired fetal development, and THC present in breast milk.
Study of 1.28 million Canadian births found prenatal cannabis use nearly doubled the risk of preterm birth and low birth weight and increased congenital anomaly risk by 71%, with female infants more susceptible.
Review found cannabis affects nearly every endocrine system: reduced fertility, altered thyroid function, blunted stress response, paradoxical diabetes effects, and modestly increased fracture risk.
Children exposed to cannabis in utero had 1 kg more fat mass, 2.6% higher body fat, and 5.6 mg/dL higher blood sugar by age 5 compared to unexposed children.
Among 251 pregnant women with opioid or alcohol problems, 43-53% also used marijuana. Younger age and polysubstance use were the strongest predictors of co-use.
Canadian clinical guideline provided GRADE-based recommendations on cannabis effects on fertility, contraception, menopause, and pelvic pain, emphasizing non-stigmatizing care.
Rhesus monkeys given daily THC edibles during pregnancy showed reduced placental blood flow, lower fetal oxygen, decreased amniotic fluid, and placental tissue damage with microinfarctions.
Rat study found prenatal THC caused sex-specific brain lipid disruptions and neuropsychiatric-like behaviors in offspring, with males more persistently affected.
Lab model of human sperm development showed cannabis exposure altered DNA methylation at autism-linked and imprinted genes.
First whole-genome sperm methylome study of cannabis exposure found 3,321 altered sites in rats, with changes detectable in offspring and associated with heart enlargement.
Quebec cohort study of 2,408 children found no significant association between in-utero cannabis exposure and ADHD risk after adjusting for confounders.
Diabetic rat study found cannabis reduced sperm motility dose-dependently and lowered testosterone, while metformin increased sperm counts but also reduced testosterone.
Colorado study found cannabis-involved pregnancy hospitalizations more than doubled after legalization, with recreational dispensary density associated with the increase.
Focus groups with 53 pregnant cannabis users found legalization reduced access barriers and stigma, and that participants trusted cannabis retailers as information sources.
Study of 99,127 pregnancies found prenatal cannabis use was more common near cannabis retailers (6.8% pre-pandemic, 8.2% during), with the pandemic increase larger for those within 10 minutes of a store.
Scoping review of animal studies found cannabinoid exposure during brain development (prenatal, adolescent) caused lasting cognitive harm, while exposure in old age showed potential cognitive benefits.
Study of 168,589 pregnancies found children of prenatal cannabis users were 43% more likely to miss their 12-month check-up, with 36% missing two or more visits by age 3.
California data showed prenatal cannabis use (4.9%) was more than double cigarette smoking (2.1%), with cannabis being the more common substance during pregnancy statewide.
California study of 34,544 births with maternal CUD found 40% higher infant mortality in the first year (1.0% vs 0.4%), driven by perinatal conditions and sudden unexpected infant death.
Survey of 105 pregnant cannabis users found 62% continued after pregnancy recognition, with those viewing use as medical four times more likely to continue.
Pregnant rat study found injected THC/CBD increased fetal inflammation while smoked cannabis reduced it, showing route of administration fundamentally changes outcomes.
Nationally representative US data showed 4.3% cannabis use during pregnancy, but screening rates for cannabis (82%) lagged behind alcohol and tobacco (~95%).
French hospital data from 2010-2019 found cannabis use during pregnancy associated with prematurity and small-for-gestational-age births compared to tobacco-only and non-using controls.
National US data found pregnant and postpartum women with mental health disorders had 2-12 times higher odds of cannabis use disorder, with 9.8% overall cannabis use prevalence.
CBD given during adolescence rescued memory deficits and restored brain plasticity markers in rats prenatally exposed to THC, suggesting a potential therapeutic window.
Qualitative study of 10 maternal health providers found they often avoid cannabis conversations with pregnant patients to maintain therapeutic relationships, despite recognizing this leaves patients without guidance.
Dublin maternity hospital data showed cannabis and cocaine use in pregnancy nearly quadrupled from 2010-2019 while opioid use declined, with high rates of complications.
Analysis of 3,373 pregnant US women found serious psychological distress associated with nearly 3x more cannabis use days and 5x more binge drinking days.
Study of 186 young pregnant women found 20% had tried CBD, with pre-pregnancy substance use as the strongest predictor.
Meta-analysis of 23 studies found a modest link between prenatal cannabis and birth defects overall, but most associations disappeared after adjustment except for two rare defects.
Cannabis-related acute care during pregnancy nearly doubled after legalization in Ontario, with associated increases in preterm birth and NICU admissions, though absolute numbers stayed small.
Cannabis-exposed pregnancies showed head circumference deficits starting in the second trimester, reaching more than 14 percentile points by birth, after controlling for other substance use.
Children prenatally exposed to both a natural disaster and maternal cannabis use had synergistically elevated psychiatric risk, with a 31-fold increase in behavioral disorders.
Prenatal cannabinoid exposure disrupted breathing regulation in rat offspring sex-specifically: males had altered CO2/O2 responses while females had increased apnea with reduced brainstem serotonin neurons.
Prenatal THC altered mouse hippocampal development through the CB1 receptor and MEF2C pathway, with effects rescued by a CB1 blocker.
Prenatal cannabinoid exposure caused adolescent rat memory deficits through reduced PSA-NCAM and imbalanced glutamate signaling, with PSA administration rescuing the impairment.
Study of 2.38 million California births found prenatal cannabis use disorder linked to 45% higher preterm risk, 47% higher SGA risk, and 86% higher infant death odds.
Review argues epigenomic evidence links cannabis exposure to birth defects, cancer, and accelerated aging through DNA methylation disruption across generations.
US ecological study found daily cannabis use and first-trimester exposure were statistically associated with autism rates in 40 million children, with exponential dose-response patterns.
Review found cannabinoid receptors throughout the placenta and evidence that THC and CBD exposure can disrupt placental development, contributing to fetal growth restriction.
Review highlighted that combined alcohol-cannabis use during pregnancy is increasingly common but virtually unstudied, despite evidence that co-use amplifies effects.
Prenatal cannabis smoke exposure in rats altered litter sex ratio, increased adult offspring anxiety, changed amygdala genes, but improved some cognitive tasks.
Prenatal THC caused lasting cognitive deficits in both male and female rats through radically different sex-specific mechanisms involving neural activity, proteins, and fatty acid depletion.
Study of 26,366 births found Black newborns were drug-tested at 3.8x the rate of White newborns without clinical justification, and cannabis legalization did not reduce the disparity.
Macaque study found prenatal THC edible exposure changed DNA methylation at autism-linked genes, with 98% of changes occurring in placenta.
Longitudinal study found prenatal tobacco and cannabis exposure associated with elevated inflammatory markers (salivary CRP) in children ages 4-6.
ABCD Study analysis of ~10,000 children found sleep protects against behavior problems, but prenatal cannabis exposure significantly weakened this protective effect.
Systematic review of 20 studies found mixed evidence on prenatal cannabis exposure and birth defects, with too few studies per organ system for strong conclusions.
Analysis of 265,000+ pregnancies identified four prenatal substance use patterns including a cannabis-predominant group (4.9%) with elevated depression and anxiety.
Prospective cohort found late prenatal cannabis exposure associated with higher language scores at 12 months in 69 exposed vs. 138 unexposed infants.
Qualitative study of 52 pregnant/lactating cannabis users found information about risks inadequate and clinicians generally unhelpful or judgmental on the topic.
Systematic review of 28 studies (523,107 patients) found no significant pooled associations between prenatal cannabis exposure and child cognitive or academic outcomes.
Systematic review of prenatal polysubstance use in the US finds cannabis commonly co-used with other substances, with widely varying prevalence estimates.
Population study of 34,309 West Virginia births found cannabis common in prenatal substance use, both alone and combined with opioids and stimulants.
Michigan study found nausea and vomiting of pregnancy associated with prenatal cannabis use amid rising potency and decreasing risk perception.
Qualitative study found COVID-19 pandemic increased stress and isolation that drove changes in prenatal cannabis use among pregnant individuals.
Large California study of 58,114 pregnancies found prenatal cannabis use associated with higher SARS-CoV-2 infection risk after controlling for confounders.
Animal study found prenatal cannabinoid receptor activation caused sex-specific epigenetic changes in offspring germ cells via histone modifications.
ABCD Study data linked prenatal cannabis exposure to blunted brain reward responses and psychotic-like experiences in youth, suggesting dopamine-related circuitry disruption.
Meta-analysis linked prenatal cannabis to 30% higher ASD risk. A large cohort study found cannabis use disorder before or during pregnancy associated with 3x higher ASD risk.
Meta-analysis of 36 studies and 19+ million subjects found prenatal cannabis linked to 25-33% higher odds of birth defects, though adjusted estimates were smaller.
Review of cohort studies and meta-analyses found cannabis use during pregnancy linked to higher risks of preterm birth, low birth weight, NICU admission, fetal death, and placental complications.
Review predicted that pregnancy hormones alter THC metabolism by inducing key liver enzymes, potentially changing how pregnant individuals experience THC effects.
Study of nearly 120,000 pregnancies found no link between early-pregnancy cannabis use and child developmental delays through age 5.5, at any frequency of use.
Study of nearly 179,000 pregnancies found no association between early-pregnancy cannabis use and child autism after adjusting for maternal factors, contrasting earlier studies.
Study of 365,000 infants found in utero cannabis exposure linked to 20% higher odds of low birth weight and 24% higher odds of being small for gestational age, with dose-response effects.
ABCD Study of 9,000+ adolescents linked prenatal cannabis exposure to frontal/parietal brain differences, with some changes partially explaining the pathway to ADHD.
Meta-analysis of 534,445 participants found prenatal cannabis slightly increased ADHD risk (13%) and offspring cannabis use (20%) but showed no link to autism, psychosis, anxiety, or depression.
Review warns that prenatal cannabis use is rising despite evidence of perinatal and neurodevelopmental risks, with healthcare providers often avoiding the topic.
Large survey found 20% of pregnant women used CBD-only products, nearly double the rate of non-pregnant women, primarily for anxiety, pain, and depression.
Two-thirds of Colorado mothers reported clinician cannabis discussions during pregnancy, but perinatal users more often trusted cannabis websites and stores for information.
Study found moderate agreement (kappa=0.49) between self-report and urine tests for prenatal cannabis use, with discordance explained by low-level use and pre-awareness consumption.
C. elegans exposed to CBD from early life showed irreversible developmental delays, with purified CBD slightly more toxic than hemp extract, though all adverse doses far exceeded human recommended levels.
Prenatal THC exposure impaired spatial memory more severely in adolescent male rats than females, with males losing hippocampal inhibitory interneurons while females gained them, suggesting fundamentally different biological responses.
Interviews with 75 clinicians and pregnant women in Canada found both groups want open, evidence-based cannabis counseling, but patients reported that real-world clinical encounters consistently fell short.
Survey of 69 US hospitals found highly variable breastfeeding policies for cannabis-using mothers, with 16% restricting breastfeeding and no consistent link between policies and state legalization or provider knowledge.
The new 9-item Cannabis Exposure in Pregnancy Tool (CEPT) captures frequency, timing, dose, and mode of prenatal cannabis use with 100% sensitivity and 82% specificity against urine testing.
JAMA study of 504 pregnant women found nearly half used cannabis, with 58% citing mental health reasons. Those using for mental health had the worst depression scores but no faster improvement than non-users across pregnancy.
Analysis of 3.1 million California pregnancies found combined prenatal cannabis and nicotine exposure associated with 2.2x infant death, 1.9x SGA, and 1.8x preterm delivery risk, exceeding the risk of either substance alone.
A California study of 5.8 million births found prenatal cannabis use disorder was associated with 30-50% higher risk of gastroschisis, with the strongest link in mothers over 34.
After Oklahoma legalized medical marijuana, neonatal THC exposure increased significantly (16.2 to 22.2 per 1,000 births) while opioid exposure showed no significant change across 16,804 births.
Prenatal THC, CBD, and THC+CBD exposure all caused low birth weight and sex-specific brain and behavioral changes in adolescent rats, with disrupted endocannabinoid signaling in the prefrontal cortex and hippocampus.
In 11,530 children from the ABCD Study, prenatal cannabis exposure was linked to subtle but reliable reductions in white matter integrity of the fornix, a brain pathway important for emotion and memory.
Interviews with 19 BIPOC pregnant cannabis users in California found they actively practiced harm reduction by reducing amounts, switching product types, and seeking regulated sources.
Qualitative analysis of an online pro-cannabis pregnancy forum found pregnant people described using cannabis for mental health, nausea, pain, and stress, often as an alternative to prescribed medications.
A longitudinal study of 894 pregnant individuals found cannabis use was associated with a sevenfold higher risk of fetal death and increased low birth weight risk.
A survey of 102 women with IBD found nearly 19% used cannabis, but most were unsure about pregnancy risks and very few had discussed cannabis use with their doctors.
A matched case-control study found prenatal cannabis exposure was linked to lower cognitive and motor scores at age three, with the most severe delays in language development among boys.
A longitudinal study of 247 dyads found prenatal tobacco-cannabis co-exposure blunted emotional reactivity in toddler boys, while continued postnatal cannabis exposure heightened reactivity.
A controlled study found high-potency prenatal cannabis exposure (198 mg THC/day average) reduced birth weight and length, with female newborns showing smaller head circumference.
National survey data found about 5% of pregnant US women used marijuana in the past month, with polysubstance use making marijuana use 2-5 times more likely.
A study of 799 pregnant patients found prenatal cannabis use was associated with 60% higher postpartum depression risk, rising to 62% in those with a history of depression.
Prenatal THC exposure in rats amplified dopamine reward responses and opioid-seeking behavior, with male offspring showing greater vulnerability to relapse.
A mouse study found endocannabinoid levels rise in the cervix during pregnancy, and inflammation-induced disruption promotes premature cervical remodeling.
Pregnant people using cannabis for nausea reported stigmatizing reactions from healthcare providers, leading many to conceal their use, while medication users received only positive feedback.
Primate pilot study found prenatal THC exposure had narrow effects on fetal muscle development overall, but activated inflammation and cytokine pathways suggesting potential for longer-term tissue damage.
Review of 59 studies finds prenatal cannabis exposure consistently predicts low birth weight followed by rapid weight gain, increased body fat, and higher glucose in childhood.
Adults prenatally exposed to cocaine started cannabis younger, and this earlier onset mediated the path to higher anxiety and more severe cannabis use in adulthood.
A mouse model of high-dose prenatal THC exposure found offspring developed anxiety, depression, cognitive problems, and increased alcohol preference, with sex-dependent effects.
Diagnosed cannabis-related disorders among pregnant women in Quebec rose 24% after Canada legalized non-medical cannabis.
In 172 Black mother-child pairs, prenatal cannabis did not predict autism behaviors. Stress was the risk factor.
Largest study (11,570 children, 34 cohorts) found no prenatal cannabis-autism link after controlling for tobacco.
Adult rats exposed to a synthetic cannabinoid before birth showed sex-specific changes in breathing control, cardiovascular function, and anxiety behavior.
First study using vaporized prenatal THC found decreased attention in rat offspring, with low doses producing more pronounced effects than high doses.
Prenatal tobacco-cannabis co-exposure affected children's emotional regulation primarily through ongoing maternal stress and substance use, not direct prenatal effects. Sensitive parenting buffered risks.
Prenatal cannabis oil exposure altered VTA dopamine neurons in male mice (disinhibited firing) but did not increase cocaine-seeking in either sex.
In pregnant mice, combined alcohol and cannabinoid exposure reduced fetal brain blood flow more than either drug alone, and reduced cerebroplacental ratios predicted perinatal death with 81% sensitivity.
Daily THC edible exposure throughout pregnancy in rhesus macaques altered fetal brain growth, histology, and molecular pathways involved in axonal guidance.
Evidence summary found prenatal cannabis exposure associated with attention problems, hyperactivity, memory challenges, and diminished academic performance in children, though confounders limit causal conclusions.
Study of 133 children found prenatal tobacco exposure increased impulsive responding, but adding cannabis did not worsen effects. Unexpectedly, co-exposed children scored higher on short-term memory.
Interviews with 16 postpartum women found fear of child protective services was the biggest barrier to disclosing cannabis use during pregnancy, compounded by perceived negative provider communication.
Meta-analysis of 57 studies found prenatal cannabis exposure increased risks of preterm birth (68%), low birth weight (160%), and NICU admission (151%), with limited cognitive effects beyond attention problems.
Australian study of 222,534 mother-child pairs found maternal cannabis use disorder associated with three-fold higher autism risk in offspring, with stronger effects in males.
Meta-analysis of 36 studies and 18 million births found prenatal cannabis exposure associated with 2-3x higher risks of cardiovascular, GI, CNS, and genitourinary birth defects.
Meta-analysis of 14 studies found prenatal cannabis exposure associated with higher ADHD symptom scores and a 30% increased risk of autism, involving over 200,000 participants.
Prenatal CBD oil (THC-free) prevented autism-like behaviors in all three core symptom domains in male rat offspring from a neuroinflammation-based ASD model.
New Mexico study found reported prenatal cannabis use paradoxically decreased after recreational legalization, while cannabis-exposed infants continued to show worse birth outcomes in both periods.
Rat study found prenatal THC disrupted stress hormone receptors and dopamine signaling specifically in male offspring, causing stress vulnerability that was correctable with a developmental intervention.
Rat study found prenatal CBD exposure caused glucose intolerance in male offspring by 3 months, with altered liver circadian clock and metabolic gene expression, despite no effects at birth.
Retrospective study found adding marijuana to tobacco during pregnancy did not produce additional adverse birth outcomes, though both groups had high rates of adverse outcomes.
Neonatal MRI found lower total brain volume in infants exposed to cannabis in utero — in a carefully controlled study excluding alcohol, tobacco, and other drug exposure.
A study of over 2 million pregnant patients found cannabis use associated with 2.7x higher depression, 5.5x higher panic disorder, 10.7x higher suicidal ideation, and 13.6x higher alcohol abuse, though confounding by underlying risk factors is likely.
In a prospective study of 9,116 pregnant individuals, biologic testing detected nearly three times more cannabis use than self-reports, with the gap widening as pregnancy progressed. Younger age, being unmarried, and high stress were associated with underreporting.
Prenatal THC exposure reprogrammed dopamine receptor expression in the prefrontal cortex of adolescent rats through epigenetic changes, with male offspring showing the strongest effects on D2 receptors, neuron excitability, and neural guidance systems.
A study of over 6,000 children found that maternal cannabis use around pregnancy was linked to behavioral problems specifically in children with autism symptoms, suggesting that neurodevelopmental vulnerability may modify the effects of prenatal cannabis exposure.
A Nature Communications study found THC reaches the ovarian follicle and causes chromosome segregation errors in human oocytes, with fertility patients testing THC-positive showing significantly lower rates of chromosomally normal embryos.
Among 82,180 pregnancies, partner substance problems were linked to 89% higher odds of prenatal cannabis use.
THC was found in 64% of positive newborn drug screens at an Arkansas hospital, with use increasing after state legalization. Exposed infants had lower birth metrics and longer hospital stays.
Cannabis-related ED visits during pregnancy increased 10% during COVID-19, with Medicaid-insured patients showing consistently elevated substance use and racial disparities in cannabis use narrowing.
Survey of 261 women found widespread uncertainty about cannabis and CBD risks during pregnancy, with no difference between pregnant and non-pregnant respondents.
Interviews with 34 pregnant cannabis users revealed most providers never asked about use, and patients feared judgment and child welfare reporting if they disclosed.
Survey of 484 postpartum mothers found only one-third received provider counseling about marijuana, despite 60% having ever used it.
National survey of 94,225 women found 6.8% of pregnant women used cannabis, with first-trimester rates reaching 10-14%, mostly by smoking.
Two pregnant women with severe cyclic vomiting were diagnosed with cannabinoid hyperemesis syndrome after the hot bathing relief pattern was identified; symptoms resolved with cannabis cessation.
Placental tissue study found cannabis use completely eliminated endocannabinoid-mediated blood vessel relaxation and greatly reduced nitric oxide signaling.
Case report of a pregnant woman with CHS unresponsive to standard anti-emetics who improved significantly with topical capsaicin cream.
Interviews with 15 birthing parents found racial bias in newborn drug testing practices, poor communication about cannabis risks in pregnancy, and calls for non-punitive approaches.
Latent class analysis of 15,429 U.S. postpartum women identified seven substance use patterns, including 5.5% who used cannabis before pregnancy but largely stopped during.
Swiss survey found 3.8% of pregnant women used CBD products and 7.6% used tobacco, but only 25% of tobacco users received cessation counseling.
Swiss study found pregnant women using cocaine/opioids had nearly 4x higher odds of adverse newborn outcomes compared to cannabis-only users.
A genome-environment study of 212 infant deaths found prenatal cannabis use associated with 3.7x higher SUID risk, strengthening to 6.0x after removing cases with genetic explanations.
Mouse study found THC diverts placental stem cell development away from nutrient-exchange cells through CB1 receptor signaling, providing a mechanism for cannabis-related pregnancy complications.
A review finds prenatal cannabis exposure affects multiple organ systems beyond neurodevelopment, including cardiovascular, metabolic, and growth outcomes.
4F-MDMB-BUTICA caused mortality, deformities, behavioral changes, and gene expression alterations in zebrafish embryos.
Fetal brain THC reaches 35-50% of maternal blood. A model predicts 3.7 nM THC from 10mg inhaled.
In a Kaiser prenatal program, 80% of 20,398 cannabis-positive pregnancies completed assessment and 88% of those needing help attended counseling.
CBD and its metabolites reduced human neural stem cell viability at clinically relevant concentrations and altered differentiation markers, raising prenatal safety concerns.
Maternal omega-3 supplementation reversed THC-induced fetal growth restriction and cardiac deficits in rat offspring, possibly through reduced endocannabinoid signaling.
A meta-analysis of 51 studies and 21 million pregnancies found cannabis use was associated with 52-75% higher odds of preterm birth, low birth weight, and small babies, even after accounting for tobacco use.
Mystery calls to 104 Arizona dispensaries found 71% of budtenders recommended cannabis for morning sickness, with only one-third proactively suggesting medical consultation first.
Among 206 pregnant women with opioid use, over 80% used tobacco (unchanged across trimesters) and about 30% used cannabis in early pregnancy, declining to 17% by the third trimester.
Lab study found two common synthetic cannabinoids promoted nerve cell growth through CB1 receptors while simultaneously damaging mitochondria, raising concerns about neurodevelopmental effects.
Prenatal THC increased anxiety in dominant mice offspring but decreased it in submissive ones, revealing that inborn temperament determines how prenatal cannabis exposure affects behavior.
Study of 257 women found cannabis use during pregnancy independently predicted higher postpartum PTSD and depression, separate from the effects of intimate partner violence.
Hospital admissions for cannabis use disorder among pregnant women are increasing, highlighting a growing clinical concern around prenatal cannabis exposure.
Mental health clinicians identify nausea as the top driver of prenatal cannabis use, with patients relying on peers for information more than healthcare providers.
Birth cohort study finds prenatal cocaine exposure leads to more marijuana use by age 21 through a chain of executive function deficits at 12 and substance use at 15.
Activating CB1 receptors in developing zebrafish causes myelin to wrap around cell bodies instead of nerve fibers, revealing a new way cannabinoids could disrupt brain development.
Mouse study finds cannabinoid receptors significantly regulate ovarian follicle development, estrogen production, and blood vessel formation, with CB2 receptors playing a key role.
Study of 128 mother-child pairs finds prenatal THC exposure linked to less body fat at birth followed by rapid postnatal growth, with shorter breastfeeding amplifying the pattern.
Two-hit rat study finds prenatal immune activation plus adolescent THC causes hidden brain changes visible on imaging and gene expression, even before behavioral symptoms appear.
Mouse embryo study discovers that both too much and too little endocannabinoid signaling causes catastrophic membrane ruptures in 40% of migrating brain cells during development.
The most comprehensive review to date (89 studies) finds prenatal cannabis exposure harmful for fetal growth and development, concluding cannabis should be avoided during pregnancy.
A narrative review of cannabis effects across the lifespan found that prenatal and adolescent exposure carries the highest neurological risk, while cannabis use among older adults is rising fastest with the least risk awareness.
An ABCD Study analysis of nearly 10,000 children found that prenatal exposure to both cannabis and tobacco was linked to more externalizing behavior problems at ages 9-11 than exposure to either substance alone.
A study of 637 breast milk samples found that those with detectable cannabis metabolites had higher protein and 11% lower fat content, with no changes in calories or carbohydrates.
Chronic CBD from weaning reversed anxiety, brain molecular changes, gut microbiota dysbiosis, and increased alcohol motivation in mice with fetal alcohol exposure, with effects varying by sex.
A study of 587,486 pregnancies found that while any cannabis use was not linked to hypertension, frequent use (2+ times weekly) was associated with 3.44 times higher odds of hypertensive disorders.
Two longitudinal studies found prenatal cannabis exposure was linked to DNA methylation changes in neurodevelopment genes, persisting from birth through age 27 across two countries.
A study of 303,178 California pregnancies found that past-year violence and unsafe living situations were linked to higher cannabis use during early pregnancy, with 7.2% of pregnancies involving cannabis use.
A review found cannabis impairs attention while nicotine enhances it in adults, but both substances harm attention development when exposure occurs prenatally.
A mouse study found prenatal THC combined with maternal stress caused additive harm to maternal behavior and offspring brain development, with sex-specific effects on anxiety, motivation, and gene expression.
Animal study found prenatal cannabinoid exposure impaired breathing reflexes and cardiovascular responses in juvenile rats, with sex-specific effects.
Rat study found THC exposure at different pregnancy timepoints produced different effects on brain immune cells and social behavior—timing matters, not just exposure.
Rat study found prenatal THC exposure during early vs late pregnancy produced opposite effects on brain immune cell activity and social behavior.
Large prospective study found ongoing cannabis use beyond the first trimester was linked to 60% higher odds of depressive symptoms later in pregnancy, while any-use overall was not significant.
Large prospective cohort found no significant link between prenatal cannabis use and child cognitive, motor, or language development at age 2, with an unexpected positive language association in girls.
Systematic review found strong animal evidence that prenatal cannabinoid exposure disrupts brain neurotransmitter systems, but identified a critical lack of human studies on this topic.
Among 508,025 Ontario children, prenatal cannabis exposure was linked to fewer primary care visits but more ER visits, hospitalizations, and psychiatrist visits through age 10.
Medical record audit found hospitals documented cannabis use in only 34% of ER visits and made substance support referrals in only 7% of admissions for pregnant women with known cannabis concerns.
Longitudinal study of 2,015 individuals found heavy drinking, but not cannabis use, was associated with higher unintended pregnancy risk among those wanting to avoid pregnancy.
In nearly 54,000 Nova Scotia pregnancies over two decades, cannabis use independently predicted prenatal anxiety, which rose from under 5% to over 20% prevalence.
Systematic review of 57 studies found prenatal cannabis consistently linked to lower birth weight across species, but not shorter pregnancies, with mixed results for other outcomes.
Systematic review of 33 studies found prenatal cannabis exposure linked to emerging self-regulation problems in young children, becoming more apparent after age 2 through multiple neurobiological pathways.
Mouse study finds oral CBD and THC during pregnancy both impaired fetal growth and caused sex-dependent behavioral changes in offspring, challenging the assumption that CBD is safe for pregnant use.
Longitudinal study found childhood trauma predicts cannabis use in new mothers, with resilience protective at low-to-moderate trauma but losing its effect at high trauma levels.
Study of 35,437 births found prenatal THC exposure alone did not predict maltreatment after policy stopped automatically substantiating it as abuse, and revealed racial bias in testing.
Mouse study found prenatal cannabis exposure impaired metabolic control in female but not male offspring, with paradoxically different effects depending on diet.
Primate study found prenatal edible THC exposure reduced infant lung volumes and altered lung gene expression through epigenetic changes at 6 months of age.
Study of 742,491 pregnant women across 9 US states found only 21% received guideline-adherent cannabis counseling, with recreational legalization states doing more screening but also more pro-cannabis advice.
Qualitative analysis of 64 Canadian cannamom social media posts found cannabis positioned as a wellness tool for achieving motherhood ideals, with product marketing embedded in community support narratives.
Study of 136 pregnant cannabis users found pandemic-era users were over twice as likely to use cannabis for symptom management, more likely to use edibles, and more likely to report physician involvement.
Study of 2,981 umbilical cord samples found THC positivity increased from 40.6% to 46.2% after Illinois legalized cannabis, with significantly higher THC concentrations in positive samples.
Study of 115 mother-infant pairs found prenatal cannabis exposure alone did not affect newborn behavior, but cannabis-exposed infants from low-income households showed reduced attention and heightened arousal.
Study of 223,068 Australian births found children exposed to maternal cannabis use disorder had 79% higher anxiety risk and 2.5x higher PTSD risk.
Australian population study found children of mothers with cannabis use disorder during pregnancy had 3.5x higher risk of disruptive behavioral disorders across all exposure windows.
Colorado surveillance data showed 13.3% of birthing individuals used cannabis perinatally, with pregnancy depression doubling the odds. Most cited medical reasons during pregnancy but shifted to recreational use postpartum.
Baboon study found alcohol dilates fetal brain arteries through CB1 cannabinoid receptors, with effects differing between male and female fetuses and across brain regions.
Evidence links prenatal cannabis to low birth weight, preterm birth, and lasting brain changes in children—with THC potency having risen from 5% to 30%.
Medical cannabis patients used cannabis during pregnancy for symptoms and while parenting for stress, despite significant stigma.
A Michigan pregnancy cohort of 584 women found that the 15% who used cannabis during pregnancy had babies with significantly smaller birth size, supporting guidelines advising against prenatal cannabis use.
A review of 64 studies found cannabis disrupts reproduction at every stage—from sperm quality to ovulation to placental function to fetal development.
Prenatal cannabis exposure may delay GABA's developmental switch from excitatory to inhibitory—disrupting the precise timing that guides how the fetal brain wires itself.
Survey of German midwives after 2024 cannabis legalization finding gaps in knowledge about prenatal cannabis risks and inconsistent screening practices.
Comprehensive review of cannabis use in pregnancy and breastfeeding, covering pharmacology, evidence on outcomes, and harm reduction counseling strategies.
Mystery shopper study finding only 40% of California budtenders advise against prenatal cannabis use, while 80% warn against tobacco — highlighting a critical public health gap.
Large study of 40,806 pregnancies showing daily preconception cannabis use increases the risk of prenatal use 2.7-fold, highlighting the need for early intervention.
Study of 200,207 pregnancies showing prenatal cannabis users initiate breastfeeding at similar rates but discontinue earlier, with 16-19% lower rates at 6-12 months.
Analysis of 356,343 pregnancies finding daily cannabis use associated with 3.8x greater odds of severe morning sickness, challenging the use of cannabis for pregnancy nausea.
Study of 297,147 infants finding prenatal alcohol (but not cannabis or nicotine) exposure associated with 37% increased risk of infant hearing loss.
Study of 3,507 pregnant cannabis users finding smoking is most common (71%), with significant sociodemographic differences in how cannabis is consumed during pregnancy.
Large study of 141,570 children finding no association between maternal prenatal cannabis use and ADHD or disruptive behavior disorders after adjusting for confounders.
Statewide Michigan study using both self-report and urine testing finds 1 in 6 pregnancies involved cannabis use, strongly linked to depression, adverse childhood experiences, and socioeconomic factors.
Qualitative study reveals low-income pregnant cannabis users are primarily motivated by emotional regulation and mental health needs, highlighting systemic barriers to support and informed decision-making.
Study finds cannabis use during pregnancy suppresses both pro- and anti-inflammatory immune signals in mothers, providing a potential biological mechanism for adverse birth outcomes.
California birth data from 2007-2021 shows combining cannabis with alcohol during pregnancy adds 21% higher risk of small babies, while adding tobacco raises preterm birth risk by 44-68%.
Analysis of 20,000+ pregnancies across 19 states finds punitive prenatal substance use policies (child abuse charges, mandatory reporting) do not reduce drug use during pregnancy.
Analysis of 194 gastroschisis cases finds maternal cannabis use associated with 2.6x higher odds of the severe complex form with bowel complications, identifying it as a potentially modifiable risk factor.
Pilot study finds a 10-week walking program reduced prenatal cannabis use from 63% to 17% while improving physical activity, anxiety, and depression — with excellent retention.
Advanced imaging revealed prenatal THC reduced copper in offspring brain tissue and altered neurochemistry in emotion-processing circuits—molecular fingerprints of exposure.
Among 13,088 pregnant women in cannabis treatment, those in legal states had 67% lower odds of completing treatment—only 28.3% completed overall.
Longitudinal mouse MRI study found prenatal THC caused enlarged ventricles in embryos followed by sustained brain growth deceleration into adulthood, with females more affected.
National data shows states with legal recreational cannabis sales had 2x higher binge drinking during pregnancy, with legalization associated with a 5 percentage point increase — an unexpected and concerning connection.
Review of animal studies shows prenatal THC and nicotine each disrupt development through epigenetic changes, with sex-specific effects persisting into adulthood.
Population-level analysis of 73,000 Arkansas pregnancies found 1.6% involved medical cannabis purchases, with daily THC averaging 137mg — far exceeding therapeutic doses for non-pregnant adults.
Large-scale ABCD Study analysis found prenatal cannabis exposure associated with altered brain network connectivity, cognitive differences, and mental health symptoms in children.
New prospective cohort enrolled 417 pregnant women in West Virginia to track how e-cigarette and cannabis use in early pregnancy affects maternal-infant outcomes.
A review of 9 MRI-based studies found prenatal cannabis exposure is linked to brain differences in multiple regions, but inconsistent methods across studies prevent firm conclusions.
Ex vivo placental study shows CBD crosses to the fetal side and dilates placental blood vessels by 36%, while THC constricts them — revealing opposing cannabinoid effects during pregnancy.
A comprehensive review finds cannabis disrupts the placental endocannabinoid system, linking use to fetal growth restriction and preeclampsia, with emerging evidence of transgenerational effects through epigenetic changes.
Prenatal THC in rats altered placental expression of genes previously linked to schizophrenia in human studies, with sex-specific effects and fetal growth restriction.
ABCD Study analysis of 7,777 children found prenatal cannabis risk was specific to post-awareness exposure, while alcohol risk was linked to pre-awareness use — timing matters differently for each substance.
CB1 receptor knockout mice show significantly lower preterm birth rates under inflammatory conditions, with reduced prostaglandins and inflammatory markers in uterine tissue.
Cannabis smoke extract caused placental cell damage beyond what THC alone produced, and blocking cannabinoid receptors did not prevent it.
Qualitative study finds most new mothers who used cannabis in pregnancy continued postpartum, citing mental health and pain, while wanting better information about breastfeeding risks.
Animal study finds melatonin protects against cannabis-induced reproductive hormone disruption in female rats, with CB1 receptors primarily responsible for the hormonal effects.
Longitudinal study of 293 families finds prenatal tobacco-cannabis co-exposure leads to childhood behavioral problems through emotion regulation difficulties, a different pathway than tobacco alone.
Mouse study shows prenatal cannabis exposure combined with adolescent stress increased risk-taking behavior, while neither factor alone had this effect.
Study of 4,270 Medicaid infants found no difference in healthcare use or developmental delay at age 3 between cannabis-exposed and unexposed babies.
Analysis of ~803,000 live births found mental health (83%) and GI symptom relief (77%) were top motivations for prenatal cannabis use, with 84% of users citing multiple reasons.
Study of over 31,000 preterm infants found maternal cannabis use disorder was not associated with increased or decreased risk of retinopathy of prematurity (aRR=1.0).
Review found prenatal cannabis exposure reduces placental inflammation markers, which was linked to behavioral issues in offspring, though research is still early.
Danish study found NAS incidence stable at 0.6 per 1,000 births, with one-third of cases not involving opioids and cannabis being the most common non-opioid substance.
ABCD Study found prenatal tobacco and marijuana exposure linked to children's behavior problems, with tobacco specifically altering connectivity between attention and default mode brain networks.
Single neonatal THC dose caused lasting spatial memory deficits in female rats but not males, with altered dendritic structure in both sexes — revealing stark sex-specific vulnerability.
NSDUH analysis found 7% of pregnant individuals use cannabis, driven by psychological distress (6x odds) and polysubstance use, while risk perception strongly deterred use.
First large NEJM study to show marijuana use in pregnancy is independently associated with lower birth weight (79g less) and shorter length, after controlling for tobacco, alcohol, and cocaine.